Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging
暂无分享,去创建一个
W. Warnica | M. Atri | K. Khalili | Pedram Akbari | A. Rattansingh | S. Deng | Saima Khowaja | S. Lee | Fatemah Nasri | Hua Lu | Pei York
[1] Y. Pei,et al. Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies. , 2020, Clinical journal of the American Society of Nephrology : CJASN.
[2] Y. Pei,et al. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation , 2019, Scientific Reports.
[3] D. Landsittel,et al. Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease. , 2019, Kidney international.
[4] A. Levin,et al. CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose. , 2019, Radiology.
[5] A. Chapman,et al. A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan. , 2018, Journal of the American Society of Nephrology : JASN.
[6] A. Paterson,et al. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing. , 2018, Journal of the American Society of Nephrology : JASN.
[7] F. De Keyzer,et al. 3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease , 2018, Pediatric Nephrology.
[8] C. Corsi,et al. Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment , 2017, American Journal of Nephrology.
[9] N. Tangri,et al. Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease , 2017, Canadian journal of kidney health and disease.
[10] P. McFarlane,et al. Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease , 2017, Canadian journal of kidney health and disease.
[11] Vicente E. Torres,et al. Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease , 2017, Kidney international reports.
[12] Kaleab Z. Abebe,et al. Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] Terry K Koo,et al. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.
[14] Philip McFarlane,et al. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] K. Bae,et al. A comparison of ultrasound and magnetic resonance imaging shows kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease , 2015, Kidney international.
[16] M. Haider,et al. Imaging-based diagnosis of autosomal dominant polycystic kidney disease. , 2015, Journal of the American Society of Nephrology : JASN.
[17] Ajay V. Srivastava,et al. Autosomal dominant polycystic kidney disease. , 2014, American family physician.
[18] H. G. Guimarães Filho,et al. Reproducibility of Renal Volume Measurement in Adults Using 3‐Dimensional Sonography , 2014, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[19] J. Grantham,et al. Why kidneys fail in autosomal dominant polycystic kidney disease , 2011, Nature Reviews Nephrology.
[20] G. Leo,et al. Renal volume assessment with 3D ultrasound , 2011, La radiologia medica.
[21] J. Grantham,et al. Clinical practice. Autosomal dominant polycystic kidney disease. , 2008, The New England journal of medicine.
[22] J. Miller,et al. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[23] E E de Lange,et al. Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging. , 1999, Radiology.
[24] E E de Lange,et al. In vitro measurement of kidney size: comparison of ultrasonography and MRI. , 1998, Ultrasound in medicine & biology.
[25] K. Liang,et al. Asymptotic Properties of Maximum Likelihood Estimators and Likelihood Ratio Tests under Nonstandard Conditions , 1987 .
[26] J. Stockman,et al. A New Equation to Estimate Glomerular Filtration Rate , 2011 .
[27] A. Paterson,et al. Unified criteria for ultrasonographic diagnosis of ADPKD. , 2009, Journal of the American Society of Nephrology : JASN.